Abstract
We previously identified metal-responsive transcription factor-1 (MTF-1) as a positive contributor to mouse fibrosarcoma growth through effects on cell survival, proliferation, tumor angiogenesis and extracellular matrix remodeling. In the present study, we investigated MTF-1 protein expression in human tissues by specific immunostaining of both normal and tumor tissue samples. Immunohistochemical (IHC) staining of a human tissue microarray (TMA), using a unique antihuman MTF-1 antibody, indicated constitutive MTF-1 expression in most normal tissues, with liver and testis displaying comparatively high levels of expression. Nevertheless, MTF-1 protein levels were found to be significantly elevated in diverse human tumor types, including breast, lung and cervical carcinomas. IHC analysis of a separate panel of fullsize tissue sections of human breast cancers, including tumor and normal adjacent, surrounding tissue, confirmed and extended the results of the TMA analysis. Taken with our previous findings, this new study suggests a role for MTF-1 in human tumor development, growth or spread. Moreover, the study suggests that MTF-1 could be a novel therapeutic target that offers the opportunity to manipulate metal or redox homeostasis in tumor cells. © 2010 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
Shi, Y., Amin, K., Sato, B. G., Samuelsson, S. J., Sambucetti, L., Haroon, Z. A., … Murphy, B. J. (2010). The metal-responsive transcription factor-1 protein is elevated in human tumors. Cancer Biology and Therapy, 9(6), 469–476. https://doi.org/10.4161/cbt.9.6.10979
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.